These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33060615)

  • 21. General Practitioners' Knowledge and Clinical Practice in Management of People with Type 2 Diabetes in Iran; The Impact of Continuous Medical Education Programs.
    Aghili R; Malek M; Baradaran HR; Peyvandi AA; Ebrahim Valojerdi A; Khamseh ME
    Arch Iran Med; 2015 Sep; 18(9):582-5. PubMed ID: 26317599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How do general practitioners implement decision-making regarding COPD patients with exacerbations? An international focus group study.
    Laue J; Melbye H; Halvorsen PA; Andreeva EA; Godycki-Cwirko M; Wollny A; Francis NA; Spigt M; Kung K; Risør MB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3109-3119. PubMed ID: 27994450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teaching general practitioners to activate older patients: The intervening role of changes in perceived communication skills.
    Wlodarczyk D; Lazarewicz M; Rzadkiewicz M; Chylinska J; Adamus M; Jaworski M; Lillefjell M; Haugan G; Espnes GA
    Patient Educ Couns; 2019 Sep; 102(9):1687-1694. PubMed ID: 31036331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does locally delivered small group continuing medical education (CME) meet the learning needs of rural general practitioners?
    Dowling S; Last J; Finnegan H; O'Connor K; Cullen W
    Educ Prim Care; 2019 May; 30(3):145-151. PubMed ID: 30747043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canadian practice assessment in chronic obstructive pulmonary disease: respiratory specialist physician perception versus patient reality.
    Hernandez P; Balter MS; Bourbeau J; Chan CK; Marciniuk DD; Walker SL
    Can Respir J; 2013; 20(2):97-105. PubMed ID: 23616966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why are some evidence-based care recommendations in chronic obstructive pulmonary disease better implemented than others? Perspectives of medical practitioners.
    Johnston KN; Young M; Grimmer-Somers KA; Antic R; Frith PA
    Int J Chron Obstruct Pulmon Dis; 2011; 6():659-67. PubMed ID: 22259242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An internet based approach to improve general practitioners' knowledge and practices: the development and pilot testing of the "ABC's of vitamin D" program.
    Bonevski B; Magin P; Horton G; Bryant J; Randell M; Kimlin MG
    Int J Med Inform; 2015 Jun; 84(6):413-22. PubMed ID: 25795505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A tailored e-learning gives long-term changes in determinants of GPs' benzodiazepines prescribing: a pretest-posttest study with self-report assessments.
    Creupelandt H; Anthierens S; Habraken H; Sirdifield C; Siriwardena AN; Christiaens T
    Scand J Prim Health Care; 2019 Dec; 37(4):418-425. PubMed ID: 31530208
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of a simple intervention on management of acute exacerbations of chronic obstructive pulmonary disease and its cardiovascular comorbidities: COREPOC study.
    Díez-Manglano J; Recio Iglesias J; Varela Aguilar JM; Almagro Mena P; Zubillaga Garmendia G;
    Med Clin (Barc); 2017 Sep; 149(6):240-247. PubMed ID: 28396131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial diagnosis and management of chronic obstructive pulmonary disease in Australia: views from the coal face.
    Bereznicki B; Walters H; Walters J; Peterson G; Bereznicki L
    Intern Med J; 2017 Jul; 47(7):807-813. PubMed ID: 28276136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitators to implementing a continuing medical education intervention in a primary health care setting.
    Reis T; Faria I; Serra H; Xavier M
    BMC Health Serv Res; 2022 May; 22(1):638. PubMed ID: 35562695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The quality of COPD care in general practice in Denmark: the KVASIMODO study.
    Lange P; Rasmussen FV; Borgeskov H; Dollerup J; Jensen MS; Roslind K; Nielsen LM;
    Prim Care Respir J; 2007 Jun; 16(3):174-81. PubMed ID: 17516009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey.
    Barnes N; Calverley PM; Kaplan A; Rabe KF
    Curr Med Res Opin; 2014 Apr; 30(4):667-84. PubMed ID: 24256026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Training GPs to improve their management of work-related problems: results of a cluster randomized controlled trial.
    de Kock CA; Lucassen PLBJ; Bor H; Knottnerus JA; Buijs PC; Steenbeek R; Lagro-Janssen ALM
    Eur J Gen Pract; 2018 Dec; 24(1):258-265. PubMed ID: 30394151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial.
    Vanhaecht K; Lodewijckx C; Sermeus W; Decramer M; Deneckere S; Leigheb F; Boto P; Kul S; Seys D; Panella M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2897-2908. PubMed ID: 27920516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measuring the impact of a live, case-based, multiformat, interactive continuing medical education program on improving clinician knowledge and competency in evidence-based COPD care.
    Drexel C; Jacobson A; Hanania NA; Whitfield B; Katz J; Sullivan T
    Int J Chron Obstruct Pulmon Dis; 2011; 6():297-307. PubMed ID: 21697994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Geographic differences in clinical characteristics and management of COPD: the EPOCA study.
    Miravitlles M; Murio C; Tirado-Conde G; Levy G; Muellerova H; Soriano JB; Ramirez-Venegas A; Ko FW; Canelos-Estrella B; Giugno E; Bergna M; Chérrez I; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):803-14. PubMed ID: 19281096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [General practice patients at risk of chronic obstructive pulmonary disease: epidemiologic survey of 3 411 patients].
    Piperno D; Bart F; Serrier P; Zureik M; Finkielsztejn L
    Presse Med; 2005 Dec; 34(21):1617-22. PubMed ID: 16327699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease.
    Franssen FM; Spruit MA; Wouters EF
    Int J Chron Obstruct Pulmon Dis; 2011; 6():493-501. PubMed ID: 22069360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.